LA RELACION ENTRE EL ESTIGMA Y LOS SINTOMAS DE LOS TRASTORNOS ESQUIZOFRENICOS




Artículos relacionadosArtículos relacionadosArtículos relacionados
Artículos afines de siicsalud publicados en los últimos 4 meses
INTERVENCIONES PSICOEDUCATIVAS PARA LOS CUIDADORES FAMILIARES DE ADULTOS CON ESQUIZOFRENIA
Nursing Research and Practice 2023(2167096):1-16
Difundido en siicsalud: 20 mar 2024
REHABILITACIÓN EMOCIONAL EN LA ESQUIZOFRENIA
Frontiers in Psychiatry 14(1250933):1-11
Difundido en siicsalud: 29 ene 2024

LA RELACION ENTRE EL ESTIGMA Y LOS SINTOMAS DE LOS TRASTORNOS ESQUIZOFRENICOS

(especial para SIIC © Derechos reservados)
Los mayores niveles de estigma se asocian con mayores niveles de síntomas positivos y de malestar emocional, tanto en forma concurrente como prospectiva.
lysaker9.jpg Autor:
Paul H. Lysaker
Columnista Experto de SIIC

Institución:
Indiana University School of Medicine


Artículos publicados por Paul H. Lysaker
Coautores
David Roe* Jamie Ringer** Molly A. Erickson*** Phillip T. Yanos**** 
University of Haifa, Haifa, Israel*
Richard L. Roudebush VA Medical Center, Indianápolis, EE.UU.**
Indiana University School of Medicine, Indianápolis, EE.UU.***
John Jay College of Criminal Justice, Nueva York, EE.UU.****
Recepción del artículo
23 de Marzo, 2010
Aprobación
27 de Agosto, 2010
Primera edición
31 de Agosto, 2010
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
La investigación sugiere que el estigma se comporta como una barrera para la autoestima y el logro de un funcionamiento psicosocial adecuado en las personas con esquizofrenia. Es menos claro cómo las experiencias estigmatizadoras se asocian con los síntomas tanto en forma concurrente como prospectiva. Para evaluar este aspecto se valoraron los síntomas positivos y de malestar emocional mediante la escala para el sindrome positivo y negativo (Positive and Negative Syndrome Scale) (PANSS), y la experiencia estigmatizadora mediante la escala del estigma internalizado de la enfermedad mental (Internalized Stigma of Mental Illness Scale), en 75 personas con esquizofrenia en dos momentos separados por 5 meses. Los mayores niveles de estigma se asociaron con mayores niveles de síntomas positivos y de malestar emocional, tanto en forma concurrente como prospectiva. Los síntomas también se asociaron prospectivamente con el grado de estigma. Los resultados de la replicación de hallazgos previos indican que existe una relación estrecha entre la experiencia estigmatizadora y los síntomas. Ambos pueden exacerbarse recíprocamente dando lugar a un círculo vicioso.

Palabras clave
esquizofrenia, estigma, síntomas, desempeño social, calidad de vida


Artículo completo

(castellano)
Extensión:  +/-7.3 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Research suggests that stigma serves as a barrier to self-esteem and the attainment of adequate psychosocial functioning among persons with schizophrenia. Less clear is how stigma experiences are associated with symptoms both concurrently and prospectively. To study this issue Positive and Emotional discomfort symptoms were measured using the Positive and Negative Syndrome Scale, and stigma experience was assessed using the Internalized Stigma of Mental Illness Scale among 75 persons with schizophrenia at two points five months apart. Greater levels of stigma were associated with greater levels of positive and emotional discomfort symptoms both concurrently and prospectively. Symptoms were also linked prospectively with level of stigma. Result replication previously findings that a close relationship exists between stigma experience and symptoms. Both may exacerbate one another in the manner of a vicious cycle.

Key words
schizophrenia, stigma, symptoms, social function, quality of life


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Salud Mental
Relacionadas: Educación Médica, Medicina Familiar, Salud Pública



Comprar este artículo
Extensión: 7.3 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Paul H. Lysaker, Indiana University School of Medicine Roudebush VA Medical Center, IN 46202, 1481 west 10th street, Indianápolis, EE.UU.
Patrocinio y reconocimiento:
Beca del VA Rehabilitation Research and Development Service
Bibliografía del artículo


1. Angermeyer MC, Matschinger H. The stigma of mental illness: Effects of labeling on public attitudes towards people with mental disorder. Acta Psychiatr Scand 108:304-309, 2003.
2. Swindle R, Heller K, Pescosolido BA, Kikuzawa S. Responses to nervous breakdowns in America over a 40-year period: Mental health policy implications. Am Psychol 55:740-749, 2000.
3. Link BG, Phelan M, Bresnhahan M, Stueve A, Pescosolido BA. Public conceptions of mental illness: Labels, causes, dangerousness and social distance. Am J Public Health 89:1328-1333, 1999.
4. Markowitz FE. The effects of stigma on the psychological well-being and life satisfaction of persons with mental illness. J Health Soc Behav 39:335-347, 1998.
5. Pescosolido BA, Monahan J, Link BG, Stueve A, Kikuzawa S. The public's view of the competence, dangerousness, and need for legal coercion of person with mental health problems. Am J Public Health 89:1339-1345, 1999.
6. Phelan JC, Link BG, Stueve A, Pescosolido BA. Public conceptions of mental illness in 1950 and 1996: What is mental illness and is it to be feared? J Health Soc Behav 41:188-207, 2000.
7. Martin JK, Pescosolido BA, Tuch SA. Of fear and loathing: The role of disturbing behavior, labels and causal attributions in shaping public attitudes toward persons with mental illness. J Health Soc Behav 41:208-233, 2000.
8. Bordieri J, Drehmner D. Hiring decisions for disabled workers: Looking at the cause. J Appl Soc Psychol 16:197-208, 1986.
9. Link BG. Understanding labeling effects in the area of mental disorders: An assessment of the effects of expectations of rejections. Am Sociol Rev 52:96-112, 1987.
10. Rüsch N, Corrigan PW, Wassel A, et al., Self-stigma, group identification, perceived legitimacy of discrimination and mental health service use. Br J Psychiatry 195:551-552, 2009.
11. Page S. Psychiatric stigma: Two studies of behavior when the chips are down. Can J Comm Ment Health 2:13-19, 1983.
12. Rüsch N, Corrigan PW, Todd AR, Bodenhausen GV. Implicit self-stigma in people with mental illness. J Nerv Ment Dis 198:150-153, 2010.
13. Lysaker PH, Roe D & Yanos PT. Toward understanding the insight paradox: Internalized stigma moderates the association between insight and social functioning, hope and self-Esteem among people with schizophrenia spectrum disorders. Schizophr Bull 33:192-199, 2007.
14. Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiat Res 121:31-49, 2003.
15. Warner R, Taylor D, Powers M, Hyman R. Acceptance of the mental illness label by psychotic patients: Effects on functioning. Am J Orthopsychiat 59:389-409, 1989.
16. Wright ER, Gronfein WP, Owens TJ. Deinstitutionalization, social rejection and the self esteem of former mental patients. J Health Soc Behav 41:68-90, 2000.
17. Siris SG. Suicide and schizophrenia. J Psychopharmacol 15:127-135, 2001.
18. Lysaker PH, Tsai J, Yanos P & Roe D. Associations of multiple domains of self-esteem with four dimensions of stigma in schizophrenia. Schizophr Res 98:194-200, 2008.
19. Yanos PT, Roe D, Lysaker PH. The impact of illness identity on recovery from severe mental illness. American Journal of Psychiatric Rehabilitation. In press.
20. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients towards psychiatric medications: Relationship to clinical variables and insight. J Clin Psychiat 65:1372-1376, 2004.
21. Katschnig H. Schizophrenia and quality of life. Acta Psychiatr Scand 102:33-37, 2000.
22. Lloyd C, Sullivan PL, Williams D. Perceptions of social stigma and its effect on interpersonal relationships of young males who experience a psychotic disorder. Austr Occup Ther J 52:243-250, 2005.
23. Dickerson FB, Sommerville J, Origoni AE, Ringel RB, Parente F. Experiences of stigma among outpatients with schizophrenia. Schizophr Bull 28:143-147, 2002.
24. Ertugrul A, Ulug B. Perception of stigma among patients with schizophrenia. Soc Psych Psych Epid 39:73-77, 2004.
25. Yanos PT, Roe D, Markus K, Lysaker PH. Pathways between internalized stigma and outcomes related to recovery in schizophrenia-spectrum disorders. Psychiatric Services 59:1437-1442, 2008.
26. Lysaker PH, Davis LW, Warman DM, Strasburger A, Beattie N. Stigma, social function and symptoms in schizophrenia and schizoaffective disorder: Associations across six months. Psychiatry Res 149:89-95, 2007.
27. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM IV. New York: Biometrics Research, 1994.
28. Kay SR, Fizsbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr Bull 13:261-276, 1987.
29. Bell MC, Lysaker PH, Goulet JB, Milstein RM, Lindenmayer JP. Five-component model of schizophrenia: Assessing the factorial invariance of the PANSS. Psychiatry Res 52:295-303, 1994.
30. Knight MTD, Wykes T, Hayward P. Group treatment of perceived stigma and self-esteem in schizophrenia: A waiting list trial of efficacy. Behavioural and Cognitive Psychotherapy 34:305-318, 2006.
31. Yanos PT, Roe D, Lysaker PH. Narrative enhancement and cognitive therapy: A new group-based treatment for internalized stigma among persons with severe mental illness. Submitted.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
Artículos relacionadosMás relacionadosAtículos relacionados
IMPORTANCIA DE LA CONEXIÓN SOCIAL EN LA DEPRESIÓN
Journal of Affective Disorders 345:358-368
Difundido en siicsalud: 9 feb 2024
MECANISMOS MOLECULARES EN LA ESQUIZOFRENIA
Current Opinion in Neurobiology 81(102731):1-10
Difundido en siicsalud: 1 mar 2024
ua31618